Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Rapid Expansion Of Peptide And Nanobody Drug Conjugates
Peptide and nanobody drug conjugates are gaining momentum, with 106 active programs identified globally. Learn more about the fast-evolving space for targeted drug delivery and competitive opportunities.
Phase I Clinical Trial Designs: Bayesian Logistic Regression Model (BLRM)
The Bayesian Logistic Regression Model (BLRM) is redefining Phase I clinical trial design by bringing flexibility, precision, and patient-centered safety into early drug development.
Phase 1 Trial In Painful Diabetic Peripheral Neuropathy
A complex Phase 1 neuropathy study with overnight stays achieved full enrollment and retention through careful planning, strong participant engagement, and disciplined operational execution.
Top 5 Challenges For Pursuing IO Therapy Clinical Trials
By leveraging tailored approaches to tackle scientific and operational challenges, sponsors can enhance trial efficiency and advance the development of groundbreaking therapies.

Reduce Avoidable Protocol Amendments By Anticipating Operational Pitfalls
5/13/2026

This report examines how amendment drivers vary across therapeutic areas and how those changes impact execution, patient burden, site workload, timelines, and study costs.
Outgrowing Excel: Implementing RTSM In A Live Phase I Trial
2/25/2026

Learn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions
5/8/2026

Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.
AI-Powered Strategy Is Redefining Patient Recruitment Performance
9/9/2025

This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.
Embedding AI And Critical IRB Operations Data To Drive Intelligent Study Design
1/28/2026

Explore how modern clinical trial design is being transformed by a rich array of data sources through this clear roadmap for navigating the evolving complexities of the industry.

A Fast, Friendly, Fair IRB Designed For Modern Research Sites

Strengthen trial compliance and data integrity by mastering GCP through practical, real-world scenarios designed to prevent costly errors and ensure audit readiness across your research team.
First In Human (FIH) Fact Sheet

Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.
Eliminate Review Friction With An Industry-First IRB Platform

Strengthen trial compliance and data integrity by mastering GCP through practical, real-world scenarios designed to prevent costly errors and ensure audit readiness across your research team.
Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle

Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
TrialKit AI: Intelligence For Clinical Trials

Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.